Teleflex Incorporated is a medical instruments & supplies business based in the US. Teleflex Incorporated shares (TFX) are listed on the NYSE and all prices are listed in US Dollars. Teleflex Incorporated employs 14,000 staff and has a trailing 12-month revenue of around $2.8 billion.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $253.41 |
|---|---|
| 52-week range | $182.37 - $355.24 |
| 50-day moving average | $240.61 |
| 200-day moving average | $245.83 |
| Wall St. target price | $262.00 |
| PE ratio | 27.9472 |
| Dividend yield | $1.36 (0.56%) |
| Earnings per share (TTM) | $8.71 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $253.41 from 2023-02-06
| 1 week (2023-01-31) | 4.10% |
|---|---|
| 1 month (2023-01-06) | -1.75% |
| 3 months (2022-11-04) | 25.21% |
| 6 months (2022-08-05) | 1.13% |
| 1 year (2022-02-07) | -19.23% |
|---|---|
| 2 years (2021-02-05) | -36.28% |
| 3 years (2020-02-07) | 372.2655 |
| 5 years (2018-02-07) | 257.2766 |
Valuing Teleflex Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Teleflex Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Teleflex Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, Teleflex Incorporated shares trade at around 28x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
Teleflex Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.1295. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Teleflex Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Teleflex Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $748.9 million.
The EBITDA is a measure of a Teleflex Incorporated's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.8 billion |
|---|---|
| Operating margin TTM | 18.58% |
| Gross profit TTM | $1.6 billion |
| Return on assets TTM | 4.7% |
| Return on equity TTM | 10.92% |
| Profit margin | 14.76% |
| Book value | $81.25 |
| Market capitalisation | $11.4 billion |
TTM: trailing 12 months
Dividend payout ratio: 14.26% of net profits
Recently Teleflex Incorporated has paid out, on average, around 14.26% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.56% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Teleflex Incorporated shareholders could enjoy a 0.56% return on their shares, in the form of dividend payments. In Teleflex Incorporated's case, that would currently equate to about $1.36 per share.
While Teleflex Incorporated's payout ratio might seem low, this can signify that Teleflex Incorporated is investing more in its future growth.
Teleflex Incorporated's most recent dividend payout was on 14 December 2022. The latest dividend was paid out to all shareholders who bought their shares by 13 November 2022 (the "ex-dividend date").
Teleflex Incorporated's shares were split on a 2:1 basis on 16 June 1997. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Teleflex Incorporated shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Teleflex Incorporated shares which in turn could have impacted Teleflex Incorporated's share price.
Over the last 12 months, Teleflex Incorporated's shares have ranged in value from as little as $182.3654 up to $355.238. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Teleflex Incorporated's is 1.016. This would suggest that Teleflex Incorporated's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.